End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 PLN | -11.11% | -.--% | -.--% |
2023 | Remedis SA Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2023 | Remedis SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 | CI |
Sales 2021 | -298K -76.12K | Sales 2022 | -711K -181K | Capitalization | 3.77M 962K |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | -2M -511K | EV / Sales 2021 | -44.8 x |
Net Debt 2021 | 5.77M 1.47M | Net Debt 2022 | 6.72M 1.72M | EV / Sales 2022 | -14.8 x |
P/E ratio 2021 |
-10.2
x | P/E ratio 2022 |
-1.41
x | Employees | 3 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 10.17% |
1 day | -11.11% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 59 | 19-06-24 | |
Director/Board Member | 33 | 14-06-23 | |
Kamil Krajewski
BRD | Director/Board Member | - | 21-01-13 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.28M | |
+14.10% | 16.66B | |
+28.06% | 16.46B | |
+8.15% | 9.44B | |
-20.73% | 7.63B | |
+11.41% | 6.33B | |
+67.32% | 5.57B | |
-4.00% | 4.69B | |
+67.65% | 4.64B | |
+0.89% | 4.44B |
- Stock Market
- Equities
- REM Stock